Disease: Bartter syndrome- antenatal- type 2
- A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels
- A novel variant in the SLC12A1 gene in two families with antenatal Bartter syndrome
- Accentuated hyperparathyroidism in type II Bartter syndrome
- Antenatal Bartter syndrome: a new compound heterozygous mutation in exon 2 of KCNJ1 gene
- Antenatal Indomethacin Use Altering the Initial Presentation of Type 4A Bartter Syndrome
- Association of Mutations in SLC12A1 Encoding the NKCC2 Cotransporter With Neonatal Primary Hyperparathyroidism
- Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis
- Bartter syndrome type III and congenital anomalies of the kidney and urinary tract: an antenatal presentation
- Bartter Syndrome-Related Variants Distribution: Brazilian Data and Its Comparison with Worldwide Cohorts
- Bartter's syndromes
- Clinical exome sequencing uncovers an unsuspected diagnosis of Bartter syndrome type 2 in a child with incidentally detected nephrocalcinosis
- Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome
- Expanding the spectrum of genetic mutations in antenatal Bartter syndrome type II
- Functional and structural characterization of PKA-mediated pHi gating of ROMK1 channels
- Functional characterization of SLC12A1 gene variants in 3 patients with Bartter syndrome type Ⅰ
- Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome
- Genetic heterogeneity in patients with Bartter syndrome type 1
- Inherited salt-losing tubulopathy: An old condition but a new category of tubulopathy
- Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel
- Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism
- Late-Onset Bartter's Syndrome Type II with End-Stage Renal Disease Due to a Novel Mutation in KCNJ1 Gene in an Indian Adult Male - A Case Report
- Long-term follow-up of patients with Bartter syndrome type I and II
- MAGED2 controls vasopressin-induced aquaporin-2 expression in collecting duct cells
- Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity
- Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins
- Na+-K+-2Cl- cotransporter type 2 trafficking and activity: the role of interacting proteins
- Nephrogenic diabetes insipidus
- Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis
- Phenotypic variability in Bartter syndrome type I
- Six cases with severe insulin resistance (SIR) associated with mutations of insulin receptor: Is a Bartter-like syndrome a feature of congenital SIR?
- The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype
- The Urinary Excretion of Uromodulin is Regulated by the Potassium Channel ROMK
- Transient hyponatremia of prematurity caused by mild Bartter syndrome type II: a case report
- Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome